These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 812129

  • 1. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences].
    Lüdemann G, Cammann R-J, Knaape H-H.
    Psychiatr Neurol Med Psychol (Leipz); 1975 Feb; 27(2):101-7. PubMed ID: 812129
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of epilepsy in children using dipropyl acetic acid (DPA)].
    Ritz A, Jacobi G.
    Fortschr Med; 1973 May 10; 91(13):590-1 passim. PubMed ID: 4633749
    [No Abstract] [Full Text] [Related]

  • 4. [Sodium salt of n-dipropylacetic acid or Depakin in the therapy of epilepsy. Preliminary note].
    Campanella G, Cantini A, Damiani A.
    Riv Neurol; 1972 May 10; 42(5):452-8. PubMed ID: 4631199
    [No Abstract] [Full Text] [Related]

  • 5. [Prognosis in primarily pure absence epilepsy].
    Wässer S, Scheidemann I, Bergmann L, Jäckel I.
    Psychiatr Neurol Med Psychol (Leipz); 1983 Apr 10; 35(4):202-9. PubMed ID: 6408659
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M, Naestoft J, Lund M.
    Ugeskr Laeger; 1977 May 02; 139(18):1073-7. PubMed ID: 404744
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine].
    de Biolley D, Sorel L.
    Acta Neurol Psychiatr Belg; 1969 Nov 02; 69(11):909-13. PubMed ID: 4994424
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of therapy-resistant child epileptics with Mogadan].
    Sörensen N, Dreyer R.
    Med Welt; 1970 Aug 15; 33():1407-10. PubMed ID: 4996293
    [No Abstract] [Full Text] [Related]

  • 10. [Relapse prognosis following reduction of drugs in epilepsy treatment].
    Janz D, Kern A, Mössinger HJ, Puhlmann U.
    Nervenarzt; 1983 Oct 15; 54(10):525-9. PubMed ID: 6417551
    [No Abstract] [Full Text] [Related]

  • 11. Depamide in the treatment of epilepsy. A clinical trial.
    Favel P, Cartier J, Gratadou JP, Gratadou G.
    Epilepsia; 1973 Sep 15; 14(3):329-34. PubMed ID: 4200578
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note].
    Dumon-Radermecker M.
    Acta Neurol Psychiatr Belg; 1969 Nov 15; 69(11):901-8. PubMed ID: 4994423
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of status epilepticus with Rivotril].
    Ketz E.
    Schweiz Med Wochenschr; 1973 Aug 11; 103(32):1134-8. PubMed ID: 4201955
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of atypical absences with a combination of succinimide and dipropylacetate (author's transl)].
    Schneble H.
    Dtsch Med Wochenschr; 1975 Jul 25; 100(30):1564-7. PubMed ID: 808402
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of sodium dipropylacetate (DPA), a new anti-epileptic drug].
    Aoki Y, Wada T, Takahashi T, Mitsutsuka K, Toraiwa S.
    No To Shinkei; 1969 Nov 25; 21(11):1297-300. PubMed ID: 4982086
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.